Apollo Endosurgery (APEN:NASDAQ) Annual Reports & Investor Relations Material

Overview

Apollo Endosurgery, Inc. is a medical device company that specializes in providing less invasive therapies for obesity and other gastrointestinal conditions. With a focus on device-based treatments that offer an alternative to invasive surgeries, Apollo is reducing healthcare complications and costs worldwide. The company's product line includes the OverStitch™ endoscopic suturing system, the ORBERA® intragastric balloon, and the LAP-BAND® adjustable gastric banding system, which are available in 70 countries. As the number of obese and gastrointestinal disease patients continues to rise globally, Apollo's innovative solutions are sure to garner interest from health professionals and investors alike.

Frequently Asked Questions

What is Apollo Endosurgery's ticker?

Apollo Endosurgery's ticker is APEN

What exchange is Apollo Endosurgery traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Apollo Endosurgery's headquarters?

They are based in Austin, Texas

How many employees does Apollo Endosurgery have?

There are 201-500 employees working at Apollo Endosurgery

What is Apollo Endosurgery's website?

It is apolloendo.com

What type of sector is Apollo Endosurgery?

Apollo Endosurgery is in the Healthcare sector

What type of industry is Apollo Endosurgery?

Apollo Endosurgery is in the Medical Appliances & Equipment industry

Who are Apollo Endosurgery's peers and competitors?

The following five companies are Apollo Endosurgery's industry peers:

- Masimo

- Abiomed

- ResMed

- IRIDEX

- Midsona